77 results
Page 3 of 4
6-K
EX-1.1
jabzl5uk um
26 Feb 20
Enlivex Therapeutics Closes $8.0 Million Registered Direct Offering
4:15pm
424B5
spp8l9pnwc7jdl ey4
26 Feb 20
Prospectus supplement for primary offering
8:23am
20-F/A
EX-12.1
s6ih7f1cuyzzyqh5 8h
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
pa4uu4kw4
31 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.1
ypgya6o2tcbff3s6rqz
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
vsf9lalze6 0w
23 Jan 20
Annual report (foreign) (amended)
4:31pm
20-F/A
EX-12.2
o45o3i d58
23 Jan 20
Annual report (foreign) (amended)
4:31pm
424B5
oztx39i1t3fqi0 2x
20 Nov 19
Prospectus supplement for primary offering
4:46pm
424B3
uudcug1i
10 Jul 19
Prospectus supplement
8:18am
F-3
plflducy0ls1ase3
28 Jun 19
Shelf registration (foreign)
9:48am
F-3
ymsxap2 78
7 Jun 19
Shelf registration (foreign)
3:31pm
6-K
EX-99.4
ri95y ss2zce
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.2
rfbus34 gwj
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
kpcd20yrp15y
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.3
zi5hf90
27 Mar 19
Securities Purchase Agreement
8:32am
6-K
EX-99.1
mohm9numhu3xxhssna9
19 Feb 19
Asset Purchase Agreement
4:57pm
6-K
EX-99.2
36onka0 0015bf
6 Dec 18
Amended Notice of Annual and Extraordinary General Meeting of the Shareholders
4:43pm